Stan Kogan
@stan-kogan.bsky.social
Epidemiologist • Director of Clinical QI, Chronic Disease & Prevention, NYC H+H • PhD student CUNY SPH • Former NYC DOHMH • #RStats • Tweets are my own
Reposted by Stan Kogan
More than half of all US adults are eligible for semaglutide for diabetes management, weight management, and cardiovascular disease.
#AHA24
Read the JAMA Cardiology study: ja.ma/3YUKDwf
#AHA24
Read the JAMA Cardiology study: ja.ma/3YUKDwf
November 18, 2024 at 9:15 PM
More than half of all US adults are eligible for semaglutide for diabetes management, weight management, and cardiovascular disease.
#AHA24
Read the JAMA Cardiology study: ja.ma/3YUKDwf
#AHA24
Read the JAMA Cardiology study: ja.ma/3YUKDwf